Axe Capital Investments

Clear market notes built around the JSE, the rand, and what matters locally.

Axe Capital Trading News shares simple market takes on the stories moving South African shares, the rand, and a handful of major currency pairs.

What you will find here:

1. JSE shares, South African companies, and the local knock-on effects of big market news.

2. The rand, interest rates, and a small group of forex pairs, with USD/ZAR at the centre.

3. Global stories only when they can actually change how a local investor might act.

Latest market stories

Here's How Many Shares of This 15%-Yielding Monthly Dividend Stock You'd Need to Cover Your Mortgage Payment

2026-09-26 18:30 • The Motley Fool Neutral Axe Cap view: Neutral

AGNC Investment, a mortgage REIT paying a 15% monthly dividend, would require an investment of approximately $170,717 (17,783 shares at $9.60) to cover the average U.S. monthly mortgage payment of $2,134. While the dividend has been maintained since early 2020, the article cautions that this strategy carries significant risks including tax implications, past dividend cuts, and concentration risk.

Axe note: High dividend yields like AGNC’s mortgage REIT come with hidden traps when viewed from a South African perspective.

Why Is PepsiCo's Stock Down 10% While the S&P 500 Is Up 13% in 2026? Here's the Only Answer I Can Think of.

2026-09-26 18:15 • The Motley Fool Mixed Axe Cap view: Selective

PepsiCo's stock has underperformed the S&P 500 by 23 percentage points in 2026, declining 10% while the broader market gained 13%. The company faces headwinds from rising inflation, consumer belt-tightening, and shifting preferences away from snacks and packaged foods. More critically, PepsiCo is being outpaced by competitor Coca-Cola, which posted 6% organic sales growth in Q2 2026 compared to PepsiCo's 2.4%. Despite its status as a Dividend King with a 4.5% yield and strong fundamentals, investors remain cautious about the consumer staples sector.

Axe note: PepsiCo's stock has fallen sharply in 2026 despite the broader market rally, weighed down by slowing growth and stronger rival Coca-Cola.

Here's Where Wall Street Analysts See Eli Lilly's Share Price Going

2026-09-26 16:32 • The Motley Fool Positive Axe Cap view: Selective

Eli Lilly's stock has underperformed the broader market in 2026 despite a strong 5-year run, trading at 40x earnings. Wall Street analysts are modestly bullish with an average price target of $1,325 (11% upside), with 25 of 30 analysts recommending buy. The expanding GLP-1 market, projected to reach $190 billion by 2045, and Lilly's strong patent protection through the late 2030s support a positive outlook despite competitive threats from Novo Nordisk.

Axe note: Strong GLP-1 drug sales power Eli Lilly but USD/ZAR dynamics temper enthusiasm.

See all market stories →

What we follow

We keep the focus on JSE shares, the rand, and the currency moves that matter most to South African investors.

JSE and rand